Literature DB >> 12862298

The Bezold-Jarisch reflex in acute inferior myocardial infarction: clinical and sympathovagal spectral correlates.

John A Chiladakis1, Nikolaos Patsouras, Antonis S Manolis.   

Abstract

BACKGROUND: The cardiodepressor Bezold-Jarisch reflex (BJR) in acute inferior myocardial infarction (AMI) is traditionally considered as an indicator of successful thrombolysis. HYPOTHESIS: The study aim was to elucidate the role of the autonomic nervous system in the pathogenesis of a BJR response in patients with AMI by tracing spectral profiles of heart rate variability (HRV).
METHODS: We studied 32 patients who presented with BJR after starting intravenous thrombolysis for an inferior AMI. Spectral components of HRV were analyzed over the three specific 5-min periods preceding and following reflex activation. Clinically, the occurrence of BJR was correlated with the outcome of thrombolysis to achieve timely reperfusion and sustained coronary artery patency.
RESULTS: The BJR was associated with early reperfusion in 94% of the patients, and with benign transient bradyarrhythmias and patent Thrombolysis in Myocardial Infarction (TIMI) grade 3 flow right coronary arteries in 89% of the patients. Spectral analysis revealed a characteristic pattern of a sympathetic predominance with an impending gradual vagal withdrawal up to the onset of BJR, as reflected by progressive increases in low-frequency and reciprocal changes in high-frequency powers.
CONCLUSIONS: The BJR in inferior AMI represents a reliable prognosticator of timely reperfusion and sustained coronary patency. Stimulation of vagal afferents in response to sympathetic overactivity may be the underlying pathogenetic mechanism promoting a BJR response.

Entities:  

Mesh:

Year:  2003        PMID: 12862298      PMCID: PMC6654613          DOI: 10.1002/clc.4950260706

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  7 in total

1.  Acute ivabradine treatment reduces heart rate without increasing atrial fibrillation inducibility irrespective of underlying vagal activity in dogs.

Authors:  Kazunori Uemura; Masashi Inagaki; Can Zheng; Toru Kawada; Meihua Li; Masafumi Fukumitsu; Masaru Sugimachi
Journal:  Heart Vessels       Date:  2016-11-14       Impact factor: 2.037

2.  Catastrophic complication - Bezold-Jarisch reflex: Case series.

Authors:  Rakesh Garg; Ajay Goila; Mridula Pawar
Journal:  Indian J Anaesth       Date:  2011-11

3.  Reversibility of High-Grade Atrioventricular Block with Revascularization in Coronary Artery Disease without Infarction: A Literature Review.

Authors:  Rhanderson Cardoso; Carlos E Alfonso; James O Coffey
Journal:  Case Rep Cardiol       Date:  2016-01-26

4.  Autonomic function and ventricular tachyarrhythmias during acute myocardial infarction.

Authors:  Theofilos M Kolettis
Journal:  World J Exp Med       Date:  2018-08-30

5.  Bezold-Jarisch reflex-mediated asystole during dobutamine stress testing: a case report.

Authors:  Nimrah Hossain; Naseem Hossain; Mohammed Al-Sadawi; Salman Haq
Journal:  Eur Heart J Case Rep       Date:  2020-11-15

6.  Post-Partum Depression Lactating Rat Model for Evaluating Ketamine's Safety as a Pharmacotherapeutic Treatment: Roles in Cardiac and Urinary Function.

Authors:  André Rinaldi Fukushima; Pedro Enrique Navas-Suárez; Juliana Weckx Peña Muñoz; Esther Lopes Ricci; Luís Antônio Baffile Leoni; Érico C Caperuto; Leandro Yanase; Jeferson Santana; Elias de França; Jan Carlo Morais O Bertassoni Delorenzi; Alcides Felix Terrivel; Gláucio M Ferreira; Mario Hiroyuki Hirata; Lorena de Paula Pantaleon; Julia Zacarelli-Magalhães; Gabriel Ramos de Abreu; Paula A Faria Waziry; Maria Aparecida Nicoletti; Helenice de Souza Spinosa
Journal:  J Cardiovasc Dev Dis       Date:  2022-09-07

Review 7.  Differential contributions of cardiac, coronary and pulmonary artery vagal mechanoreceptors to reflex control of the circulation.

Authors:  Jonathan P Moore; Lydia L Simpson; Mark J Drinkhill
Journal:  J Physiol       Date:  2022-08-29       Impact factor: 6.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.